These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37807322)

  • 1. STAT3 promotes migration and invasion of cholangiocarcinoma arising from choledochal cyst by transcriptionally inhibiting miR200c through the c-myb/MEK/ERK signaling pathway.
    Liu W; Fan L; Shao B; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):136-142. PubMed ID: 37807322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonorchis sinensis granulin promotes malignant transformation of human intrahepatic biliary epithelial cells through interaction with M2 macrophages via regulation of STAT3  phosphorylation and the MEK/ERK pathway.
    He Q; Pan X; Yin Y; Xu A; Yi X; Wu Y; Li X
    Parasit Vectors; 2023 Apr; 16(1):139. PubMed ID: 37095578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
    Huang M; Huang B; Li G; Zeng S
    BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
    Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
    Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
    BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
    Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
    Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
    Blechacz BR; Smoot RL; Bronk SF; Werneburg NW; Sirica AE; Gores GJ
    Hepatology; 2009 Dec; 50(6):1861-70. PubMed ID: 19821497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway.
    Tuponchai P; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    J Cancer Res Ther; 2019; 15(1):157-163. PubMed ID: 30880773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.
    Saengboonmee C; Seubwai W; Pairojkul C; Wongkham S
    Sci Rep; 2016 Jan; 6():18995. PubMed ID: 26743134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.
    Indramanee S; Sawanyawisuth K; Silsirivanit A; Dana P; Phoomak C; Kariya R; Klinhom-On N; Sorin S; Wongkham C; Okada S; Wongkham S
    Sci Rep; 2019 Nov; 9(1):17266. PubMed ID: 31754244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
    Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
    EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
    Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors.
    Ewald F; Nörz D; Grottke A; Hofmann BT; Nashan B; Jücker M
    Invest New Drugs; 2014 Dec; 32(6):1144-54. PubMed ID: 25152244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
    Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
    Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor.
    Obchoei S; Detarya M; Boonnate P; Saranaruk P; Vaeteewoottacharn K; Mahalapbutr P; Okada S; Wongkham S
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3379-3386. PubMed ID: 36308362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.
    Wang S; Zhang X; Wang G; Cao B; Yang H; Jin L; Cui M; Mao Y
    BMC Cancer; 2019 Nov; 19(1):1160. PubMed ID: 31783811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
    Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P
    PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.